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Esophageal perforation: Continuing challenge to treatment
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a b s t r a c t
Esophageal perforation carries with it a high morbidity and mortality if not treated appropriately and aggressively. Three approaches are available for the
treatment of esophageal perforation: conservative, endotherapy, and surgery. The location viz. cervical, thoracic, or abdominal portions of the esophagus
and size of the perforation inﬂuence treatment choice. Cervical perforations are usually small and can be treated conservatively as the perforation or leak
is also contained within the triangle of Killian in the neck. Most cervical perforations have a good outcome with conservative treatment with intravenous
antibiotics and nil by mouth. Treatment of thoracic perforations depends very much on the size of the perforation. Small perforations due to sclerotherapy
injection, for example, can be treated conservatively. Endotherapy can help avoid surgery in other cases: small tears from endoscopic insertion can be
clipped and esophageal ﬁstulae can be injected with ﬁbrin glue. Larger perforations can be treated with stent placement if the dehiscence of the lumen
circumference does not exceed 70%. Stent placement with self-expandable fully-covered plastic and metallic stents or partially-covered metallic stents
has been used with fairly good success. One of the problems with stent placement is the migration of these stents. Perforation of the intra-abdominal
portion of the esophagus often results in a very rapid development of peritonitis and sepsis and surgery is usually recommended. Surgery is manda-
tory in any part of the esophagus when the perforation is large or when patients do not improve with conservative or endoscopic treatment. In very ill
patients, esophageal exclusion surgery can be carried out until the patient’s general condition stabilizes. In cases of a diseased esophagus such as corrosive
injury related perforations or cancer of the esophagus, esophageal replacement surgery should be contemplated with total esophagectomy and gastric
pull-up surgery or creation of a neoesophagus with colonic interposition.
Copyright  2013, Society of Gastrointestinal Intervention. Published by Elsevier.
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Esophageal perforation carries with it a high morbidity and
mortality rate if not treated appropriately and aggressively.1–3
Mortality rates for esophageal perforation range from 10% to 30%
in most studies.4,5 In a retrospective review, intrathoracic perfora-
tions had a mortality rate of 18%, followed by cervical perforations
with 8% mortality rate, and perforations at the gastroesophageal
junction with 3% mortality rate.2 Esophageal perforations can have
different etiologies. Spontaneous perforations occur as a result of a
sudden increase in intra-abdominal pressure during forceful
vomiting, such as in Boerhaave’s syndrome. Iatrogenic perforations
may result from diagnostic and therapeutic endoscopic procedures,
as complications of thoracic surgeries, and ingestion of caustic
substances. Perforations can also occur in diseased esophagus with
malignancy and infection. In a retrospective review of esophageal
perforations, 51% were iatrogenic and 33% were spontaneous per-
forations.1 Several prospective studies showed risks of perforation
for diagnostic upper endoscopy to be 0.05% or less.6,7 However, the1 Jonelta Foundation School of Medicine, University of Perpetual Help Rizal, Manila, Philippi
2GI Endoscopy Unit, University of Malaya Medical Center, Kuala Lumpur, Malaysia
Received 2 December 2012; Revised 8 February 2013; Accepted 13 February 2013
* Corresponding author. GI Endoscopy Unit, Division of Gastroenterology and Hepatol
E-mail address: klgoh56@gmail.com (K.-L. Goh).
2213-1795 Copyright  2013, Society of Gastrointestinal Intervention. Published by Else
http://dx.doi.org/10.1016/j.gii.2013.02.002perforation risk increases to 2–10% with therapeutic intervention,
such as dilatation of strictures.7
Several factors determine the successful outcome of treatment
and these include the time interval between diagnosis of perfora-
tion and treatment, the location of the perforation,1,8,9 the cause of
the perforation, the underlying esophageal disease, and the pres-
ence of comorbid illness.1,2
Three approaches are available for the treatment of esophageal
perforation: conservative, endotherapy, and surgery. In this review,
we will discuss the importance of several clinical factors in the
diagnosis and treatment of esophageal perforation.Diagnosis
Clinical manifestations
In a retrospective review of esophageal perforations by Abbas
et al, esophageal perforations had a median time of diagnosis of 12nes
ogy, University of Malaya, 50603 Kuala Lumpur, Malaysia.
vier. Open access under CC BY-NC-ND license.
Fig. 2. Gastrograﬁn study showing contrast leak in the distal esophagus (arrow).
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chest pain, which is present in 70–80% of cases.8,10 However, the
clinical presentation of esophageal perforation depends on the
location of the perforation.
Cervical perforations can present with neck pain, dysphonia,
hoarseness, and cervical dysphagia.10 Subcutaneous cervical
emphysema has been observed, in 30% of cases.8 Thoracic perfo-
rations present with acute chest pain, and in 30% of cases, back pain
or radiation to the back.8 Perforations at the gastroesophageal
junction can manifest as acute abdominal pain, with signs of
peritonitis and rarely gastrointestinal bleeding.10 Pain can be
experienced at the back or epigastric area, whichmay be referred to
the shoulder, as a result of diaphragmatic irritation.11 Vomiting and
shortness of breath associated with pain can be seen in 25% of
cases.10 Signs of systemic inﬂammatory response also develop such
as tachycardia, tachypnea, and fever. Fever is an invariable ﬁnding
50% of the time, but is considered as a late sign.8,10
Diagnostic imaging
Imaging modalities that are useful in the diagnosis and work up
of esophageal perforation include a plain chest radiograph, Gas-
trograﬁn upper gastrointestinal study, chest and upper abdomen
CT scan, and endoscopy. The most common ﬁnding in a chest
radiograph is pneumomediastinum, occurring in 42% of cases, fol-
lowed by pneumothorax and pneumoperitoneum (Fig. 1).8 Radio-
graphically evident subcutaneous emphysema is seen in 95% of
cervical perforations.11 However, the extent and location of the
perforation is difﬁcult to assess in a plain chest radiograph. Awater-
soluble contrast swallow or Gastrograﬁn study can localize the site
and extent of perforation as seen by extravasation of contrast
(Fig. 2). A negative study, however, does not exclude the presence of
a perforation and a repeat study can be done after 4–6 hours.10
Chest and upper abdomen CT scan with oral contrast can better
visualize the site and degree of containment of the perforation
(Fig. 3).10 Endoscopic evaluation provides direct visualization of the
defect (Fig. 4). However, the use of endoscopy in the evaluation ofFig. 1. Chest radiograph showing pneumoperitoneum (arrow). Fig. 3. Coronal chest computed tomography showing pneumomediastinum (arrow).
Fig. 4. Endoscopic view of esophageal perforation after stricture dilatation, showing
the adventitia layer (arrow).
Fig. 5. Successful stent placement showing the proximal end of the stent (arrows).
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result in pneumomediastinum and cervical emphysema, which
may further aggravate the condition. Although several studies have
utilized carbon dioxide for insufﬂation during esophageal submu-
cosal dissection to minimize mediastinal emphysema, its utility in
esophageal perforation has yet to be determined.12,13
Treatment
Over the years, despite development of novel techniques and
recommendations to treat esophageal perforation, the goals of
treatment remain the same: to treat infection, minimize and pre-
vent further septic contamination; to provide nutritional support;
and to restore the continuity of the digestive tract.9,14
Location of the perforation
Cervical perforations are often iatrogenic, such as during intu-
bation with a gastroscope. Cervical tears can usually be treated
conservatively as the perforation or leak is contained within the
triangle of Killian in the neck. Endoscopic therapy with clipping is
possible but visualization of the area may be difﬁcult and endo-
scopic stent placement may not be feasible. Most cervical perfo-
rations have a good outcome with conservative treatment with
intravenous antibiotics and nil by mouth.
Treatment of thoracic perforations depends on the size of the
perforation. Small perforations (e.g., due to sclerotherapy injection)
can be treated conservatively. Small tears from endoscopic inser-
tion can be clipped. However, successful closures of spontaneous
perforations by endoscopic clipping have been reported in recent
years.15,16 Esophageal ﬁstulas can be injected with ﬁbrin glue.17
Stent placement with self-expandable fully covered plastic and
metallic stents or partially covered metallic stents has been used
with fairly good success (Fig. 5).18 Migration is a particular problem
with fully covered stents where it has been reported in up to 25% of
cases.19 With conservative or endotherapy, simultaneous drainage
of any mediastinal or pleural collection of ﬂuid or pus should be
carried out and patients put on intravenous antibiotics.
Perforation of the intra-abdominal portion of the esophagus
often results in a very rapid development of peritonitis and sepsis
and surgery is usually recommended. Small leaks or perforation,
such as a small tear from balloon dilatation or from sclerotherapy,
can be treated with stent placement across the cardio-esophageal
junction. Larger tears, such as in Boerhaave’s syndrome or sponta-
neous barotraumatic rupture of the esophagus, will require surgery.Conservative treatment
Early recognition of iatrogenic perforations, within 6 hours or
less than 24 hours, correlates with better prognosis and can be
managed conservatively.8,9 Conservative management includes nil
by mouth, intravenous ﬂuids and antibiotics, total parenteral
nutrition, nasogastric tube, and chest drainage. In a 10-year retro-
spective study by Hasan et al, conservative management of esoph-
ageal perforation had a survival of 84.6%, mortality rate of 15%, with
chest infections as the most common complication in 46% of cases.8
Their study also revealed that perforations had favorable outcomes
when diagnosed within 6 hours. In another retrospective review,
successful nonoperative therapy resulted in shorter hospitalizations,
fewer complications, and lower mortality rates compared to oper-
ative treatment.2 However, conservative management should be
limited to patients who have a localized contrast extravasation on
imaging.5,8 Other indications for conservative treatment are the
absence of infective syndrome, cervical or thoracic perforations,
intramural perforation, and nontumoral perforation.9
Conservative management of perforations can be considered in
small perforations and with the following features: diagnosis made
early and perforation contained within the neck and mediastinum;
drainage into the esophageal lumen shown by contrast imaging;
injury does not occur in neoplastic tissue or corrosive injury; in the
abdomen or proximal to an obstruction; and absence of systemic
sepsis and availability of interventional radiological and surgical
expertise. In all cases managed conservatively, nutritional support
and the use of broad spectrum antibiotics as well as appropriate
radiologically guided drainage of localized collections of ﬂuid and
pus should be carried out at the same time.8,20,21 Total parenteral
nutrition, broad-spectrum antibiotics, and proton pump inhibitors
should be given for a period of 14–21 days.9 Patients aremaintained
nil by mouth for an average of 7 days until check contrast swallows
are performed to document healing and facilitate diet progression
to oral ﬂuids.8,9 Successful esophageal healing with conservative
treatment has been reported to be as high as 96%, with an overall
mortality of 4.2%.22Endoscopic therapy
Endoscopic therapy of esophageal perforations aims to restore
continuity of the esophagus for early feeding, prevent contamina-
tion of the mediastinum, and facilitate re-epithelialization of the
mucosal defect. This can be achieved by using hemoclips and stents
to seal the mucosal defect. Endoscopic hemoclipping has been
Fig. 6. Stent removal after 6 weeks, showing re-epithelialization and closure of defect
(arrows).
Gastrointestinal Intervention 2013 2(1), 1–64shown to be successful for defects 3–25 mm in size and less than
25% of the esophageal circumference and a median healing time of
18 days.23,24 A novel over-the-scope clip has been recently devel-
oped to successfully close perforations up to 30 mm in diam-
eter.25,26 Larger perforations can be treated with stent placement if
the dehiscence of the lumen circumference does not exceed 70%.27
Various stents are commercially available for stenting esopha-
geal perforations; these include Ultraﬂex stent (Boston Scientiﬁc,
Natick, MA, USA), Niti-S stent (TaeWoong Medical, Gyeonggi-do,
Korea), Polyﬂex stent (Boston Scientiﬁc), and Flamingo Wallstent
(Boston Scientiﬁc). In a systematic review by van Boeckel et al,
stenting of esophageal perforations with fully covered self-
expandable metal stents (FSEMS), partially covered self-
expandable metal stents (PSEMS), and self-expanding plastic
stents (SEPS) had an overall clinical success rate of 85%.19 Surgical
interventions were only done in 13% of the cases. However, stent
migration was noted to be highest in SEPS followed by fully-
covered metallic stents and PSEMS with migration rates of 31%,
26%, and 12%, respectively.19 Stent migration is a common problem,
particularly for covered stents because there is nothing to hold the
stents in place and deployment of the largest diameter stents is
recommended.19 In a retrospective study by Swinnen et al, closure
of leak after PSEMS removal was 77.6%.28 In several instances tissue
overgrowth and hyperplasia render the stent adherent to theFig. 7. Treatment approach toesophagus limiting its retrieval. A second stent is then inserted
through the initial stent to induce pressure necrosis of the hyper-
plastic tissue in-growth and stent retrieval can be attempted after 2
weeks.28 In an observational study, Fischer et al were able to
demonstrate that early stent placement, average time delay of 45
minutes, resulted in successful healing of esophageal perforation
and shorter duration of hospital stay.29 A novel biodegradable stent
has recently been developed to eliminate the problems of stent
retrieval. These stents are covered with biodegradable poly-
dioxanone monoﬁlament with a polyurethane skeleton. In a series
by Cerná et al, covered biodegradable stents (SX Ella-BD; ELLA-CS,
Hradec Králové, Czech Republic) were used to treat anastomotic
esophageal leaks and perforation and technical success was 100%,
while clinical success was achieved in 80% of the cases.30 The stent
was ﬁxed into position by balloon dilatation. The follow-up pro-
tocol described in the series include esophagography after 2 days,
radiograph of the stent every 4 weeks until complete degradation
was observed and endoscopy after 12 weeks of stent implantation.
Stent degradation was seen at around 11–12 weeks and was
dependent on pH, therefore stents placed at the distal esophagus
near the cardioesophageal junction were degraded earlier. A ran-
domized study comparing SEPS with biodegradable stents in the
treatment of refractory esophageal strictures showed that stent-
related complications resulting in dysphagia were higher after
biodegradable stent placement compared to SEPS, but stent
migration rates were similar.31 The main beneﬁt of biodegradable
stents is that stent removal is not required after completion of
therapy, minimizing the number of reinterventions.
The optimal time of stent placement ranges from 4 weeks to 6
weeks to avoid secondary perforation, hemorrhage, or impaction of
the stent9 (Fig. 6). Stent retrieval complications, such as bleeding,
stent fractures, and impaction, were noted to be more common for
stents extracted beyond 6 weeks.32 However, larger defects may
require more than 6 weeks to heal and the initial stent should be
replaced within 6 weeks to prevent stent embedding.32Surgery
The surgical approach for the treatment of esophageal per-
forations is inﬂuenced by the location and size of the perfora-
tion, viability of the esophageal mucosa, degree of local sepsis,esophageal perforations.
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the esophagus when the perforation is large or when patients do
not improve with conservative or endoscopic treatment. The
latter usually happens when diagnosis of the perforation is
delayed and if the perforation is noncontained resulting in
mediastinal or peritoneal contamination and systemic sepsis.2
Primary repair with suture of perforation with reinforcement
ﬂaps is the main surgical treatment and has a favorable outcome
especially if done within 24 hours of diagnosis.33–35 However, in
the presence of empyema, debridement and pleural decortica-
tion are indicated to obtain full lung expansion and facilitate
sealing of the defect.9
In very ill patients, esophageal exclusion surgery can be carried
out until the patient’s general condition stabilizes. The aim of sur-
gery is to achieve primary repair of the perforation but identiﬁca-
tion of the perforation may not be easy. Appropriate cleaning and
debridement of surrounding necrotic tissue with placement of
drains close to the site of perforation are important; T-tube
drainage has successfully provided a preferential ﬂow of inﬂam-
matory debris to facilitate wound healing.36,37 Repair of perforation
can be reinforced with muscle or pleural ﬂaps.9 A laparoscopic or
thoracoscopic approach is increasingly used for such repairs.38,39 In
cases of a diseased esophagus such as corrosive injury related
perforations or cancer of the esophagus, esophageal replacement
surgery should be contemplated with total esophagectomy and
gastric pull-up surgery or creation of a neoesophagus with colonic
interposition.40 Fig. 7 summarizes the treatment approach to
esophageal perforations.
Conclusion
Esophageal perforation is a life-threatening condition that must
be recognized and addressed aggressively. The treatment of
esophageal perforation is dependent on various clinical factors,
technology, and level of expertise available. Conservative man-
agement is possible for small and contained defects in the absence
of sepsis and aggravating underlying comorbid illnesses. Minimally
invasive treatment or endotherapy is a viable option for most
esophageal perforations especially with the development of newer
biodegradable stents. Surgical treatment is indicated for larger
defects and in overt sepsis requiring drainage and in perforations
involving diseased esophagus. The different treatment modalities
of esophageal perforation are not exclusive of each other but may
be used altogether in the management of the condition. Further
studies and technology may aim to improve the currently available
endoscopic treatment modalities, and to develop novel techniques
in the treatment of esophageal perforation.
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